These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1756256)

  • 21. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol.
    Clarke R; van den Berg HW; Murphy RF
    J Natl Cancer Inst; 1990 Nov; 82(21):1702-5. PubMed ID: 2231758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML
    J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of lipoidal derivatives of estradiol-17-beta in human mammary cancer tissue and cell lines.
    Adams JB; Vrahimis R; Young CE
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):751-8. PubMed ID: 1659870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER.
    Jeng MH; Jiang SY; Jordan VC
    Cancer Lett; 1994 Jul; 82(2):123-8. PubMed ID: 8050081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity.
    Gadd SL; Hobbs G; Miller MR
    Toxicol Sci; 2002 Apr; 66(2):233-43. PubMed ID: 11896290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosensitivity of human breast cancer cell lines of different hormonal responsiveness. Modulatory effects of oestradiol.
    Villalobos M; Becerra D; Núñez MI; Valenzuela MT; Siles E; Olea N; Pedraza V; Ruiz de Almodóvar JM
    Int J Radiat Biol; 1996 Aug; 70(2):161-9. PubMed ID: 8794845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelationship between estradiol and tamoxifen responses for clinical breast carcinoma cells cultured on contact-sensitive plates.
    Matsuoka H; Nakamura Y; Ueo H; Sugimachi K; Tomoda H; Saito T; Seo Y
    Jpn J Cancer Res; 1994 Jun; 85(6):619-25. PubMed ID: 8063615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
    Laplante Y; Cadot C; Fournier MA; Poirier D
    Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
    He FJ; Wang J; Niu JZ; Wang JF
    Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.
    Kawamura I; Mizota T; Lacey E; Tanaka Y; Manda T; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Werner HM; Franke HR; Vermes I
    Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
    Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.
    Masamura S; Santner SJ; Heitjan DF; Santen RJ
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2918-25. PubMed ID: 7559875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
    Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
    Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the expression and binding properties of the estrogen receptor in MCF-7 breast cancer cells during growth inhibition by tamoxifen and cisplatin.
    Otto AM; Schubert S; Netzker R
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):305-11. PubMed ID: 11710631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function.
    van der Burg B; van der Leede BM; Kwakkenbos-Isbrücker L; Salverda S; de Laat SW; van der Saag PT
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):149-57. PubMed ID: 8386111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.